Which has grown faster, CORT or TEM?

Over the past five years, TEM grew revenue faster — CORT at a 19.35% CAGR versus TEM at 38.24%.

Is CORT or TEM more profitable?

CORT runs the higher net margin — CORT at 6.61% versus TEM at -17.77%.

Corcept Therapeutics Incorporated (CORT) vs Tempus AI, Inc. (TEM)

A side-by-side comparison of Corcept Therapeutics Incorporated and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CORT

Corcept Therapeutics Incorporated

$12.93B

$119.63HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

TEM

Tempus AI, Inc.

$14.16B

$80.85HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — CORT vs TEM

growth of $100 · dividends reinvested · last 2y

CORT +287.3% (+96.8%/yr)TEM +107.6% (+44.1%/yr)CORT compounded faster over this window

CORT TEM

CORT vs TEM: by the numbers

•TEM is the larger company ($14.16B vs $12.93B market cap).
•CORT is profitable (6.61% net margin) while TEM runs a net loss (-17.77%).
•TEM grew revenue faster over the past five years (38.24% vs 19.35% CAGR).

Metrics side by side

Valuation

Metric	CORT	TEM
P/E ratio	284.83	N/A
P/S ratio	15.57	9.89
P/B ratio	18.32	31.84
EV / EBITDA	1453.84	N/A
FCF yield	0.83%	N/A

Profitability

Metric	CORT	TEM
Gross margin	98.30%	63.98%
Operating margin	0.77%	-19.76%
Net margin	6.61%	-17.77%
ROE	7.78%	-57.18%
ROIC	0.87%	-14.34%

Growth (annualized)

Metric	CORT	TEM
Revenue CAGR (5Y)	19.35%	38.24%
EPS CAGR (5Y)	0.64%	N/A
FCF CAGR (5Y)	-4.40%	N/A
Total return CAGR (5Y)	43.90%	N/A

Frequently asked

Which has grown faster, CORT or TEM?: Over the past five years, TEM grew revenue faster — CORT at a 19.35% CAGR versus TEM at 38.24%.
Is CORT or TEM more profitable?: CORT runs the higher net margin — CORT at 6.61% versus TEM at -17.77%.

Go deeper

Full CORT analysis Full TEM analysis Interactive comparison tool

Dig into the metrics

Corcept Therapeutics P/E ratio Corcept Therapeutics ROE Tempus AI ROE Corcept Therapeutics operating margin Tempus AI operating margin Corcept Therapeutics revenue growth Tempus AI revenue growth Corcept Therapeutics free cash flow Tempus AI free cash flow

Corcept Therapeutics & Tempus AI appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.